FDA Inspection
Shine & Pretty USA CorporationShine & Pretty USA Corporation – FDA Inspection, Mar 4, 2020
Record Details
This FDA Inspection record concerns Shine & Pretty USA Corporation, with an inspection on March 4, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- March 4, 2020
- Product Type
- Drugs
View Company Profile
ID · d7901713-cae0-4baf-879b-efb56bfc6c96
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1120528
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
5- 21 CFR 211.42(a)Buildings of Suitable Size, Construction, Location
- 21 CFR 211.160(b)(4)Establishment of calibration procedures
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.192No written record of investigation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Shine & Pretty USA Corporation
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 23, 2025 | VAI | Los Angeles District Office | Drug Quality Assurance |
| August 12, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 7, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 17, 2008 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Shine & Pretty USA Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.